Model Number 0185 |
Device Problems
Failure to Capture (1081); Appropriate Term/Code Not Available (3191); High Capture Threshold (3266)
|
Patient Problems
Erosion (1750); Unspecified Infection (1930); Heart Failure (2206); Ulcer (2274); Thrombosis/Thrombus (4440); Heart Failure/Congestive Heart Failure (4446)
|
Event Date 03/11/2014 |
Event Type
Death
|
Manufacturer Narrative
|
This initial report was not submitted previously.As per request by the fda on january 31, 2024, the initial report has been resubmitted in an effort to release follow-up 001 from hold status.
|
|
Event Description
|
It was reported that this right ventricular (rv) lead exhibited loss of capture (loc) and high threshold measurements and was surgically abandoned.Approximately one month later this system was explanted due to infection and erosion.Approximately 2 months later a patient advocate contacted boston scientific to report that this patient had died.According to the patient advocate, this patients condition did not improve following the explant of this rv lead.Subsequently, this patient developed several co morbidities including another infection, blood clots, heart failure and internal bleeding ulcer.This patient was discharged from the hospital to a nursing home and shortly after this patient was transferred to hospice where they expired.
|
|
Event Description
|
It was reported that this right ventricular (rv) lead exhibited loss of capture (loc) and high threshold measurements and was surgically abandoned.Approximately one month later this system was explanted due to infection and erosion.Approximately 2 months later a patient advocate contacted boston scientific to report that this patient had died.According to the patient advocate, this patients condition did not improve following the explant of this rv lead.Subsequently, this patient developed several co morbidities including another infection, blood clots, heart failure and internal bleeding ulcer.This patient was discharged from the hospital to a nursing home and shortly after this patient was transferred to hospice where they expired.
|
|
Manufacturer Narrative
|
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.This follow-up 001 report was originally submitted to the fda on june 13 2014.
|
|
Event Description
|
Boston scientific received information that this product was part of a system revision due to infection and erosion.There were no additional adverse effects reported.The product was explanted.Boston scientific received information in late-may 2014 that this patient advocate contacted boston scientific's latitude patient services to report that this patient had died in early (b)(6) 2014.According to the patient advocate, the patient's condition did not improve following the explant of this recently implanted device and right ventricular (rv) 4-site defibrillation lead.At the time of the explant procedure, two inactive leads that had been surgically capped were also explanted.Subsequently, the patient developed several co-morbidities including another infection, blood clots, heart failure and internal bleeding (ulcer).The patient was discharged from the hospital to a nursing home.Shortly thereafter, the patient was transferred to hospice where the patient died.
|
|
Search Alerts/Recalls
|